PRMT5 and pancreatic neoplasm: As observed in Figure 5A‐B, PRMT5 knockdown decreased the phosphorylation level of EGFR (at Y1068 and Y1172) in pancreatic cancer cells, while ectopic PRMT5 re‐expression reversed these changes.